论文部分内容阅读
目的对三联疗法治疗反流性食管炎的临床效果进行观察。方法将长葛市人民医院自2011年8月至2013年8月收治的90例反流性食管炎患者随机分为观察组与对照组,每组45例,观察组采用奥美拉唑、阿莫西林及甲硝唑联合治疗,对照组采用雷尼替丁、吗丁啉治疗,比较两组治疗前后症状积分变化、临床疗效及不良反应发生情况。结果观察组、对照组治疗总有效率分别为95.6%、71.1%,二者比较差异有统计学意义(P<0.05);观察组临床症状积分改善情况明显优于对照组,不良反应发生率小于对照组,两组比较差异均有统计学意义(P<0.05)。结论采用以奥美拉唑为主要药物的三联疗法能够有效治疗反流性食管炎,不良反应发生率低,值得推广应用。
Objective To observe the clinical effect of triple therapy on reflux esophagitis. Methods 90 patients with reflux esophagitis admitted from August 2011 to August 2013 in Changge People’s Hospital were randomly divided into observation group and control group, with 45 cases in each group. The observation group was omeprazole Combination of moxillin and metronidazole, the control group with ranitidine, domperidone treatment, before and after treatment, changes in symptom scores, clinical efficacy and adverse reactions. Results The total effective rates of the observation group and the control group were 95.6% and 71.1%, respectively, with significant difference (P <0.05). The improvement of clinical symptom scores in the observation group was significantly better than that in the control group, and the incidence of adverse reactions was less than The difference between the two groups was statistically significant (P <0.05). Conclusions The triple therapy with omeprazole as the main drug can effectively treat reflux esophagitis with low incidence of adverse reactions and is worth popularizing and applying.